end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AmortizationOfFinancingCosts,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConvertibleDebtNoncurrent,DebtInstrumentCarryingAmount,DebtInstrumentInterestRateStatedPercentage,DebtInstrumentUnamortizedDiscountNoncurrent,DeferredCosts,DeferredFinanceCostsNoncurrentNet,DeferredIncomeCurrent,Depreciation,DividendsCommonStock,DueToRelatedPartiesCurrent,EarningsPerShareBasic,EarningsPerShareDiluted,EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability,EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAdjustmentOfWarrants,FairValueLiabilitiesLevel1ToLevel2TransfersAmount,FairValueLiabilitiesLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3,FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss,FinancialLiabilitiesFairValueDisclosure,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExaminationPenaltiesAndInterestAccrued,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxExpenseBenefit,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInInterestPayableNet,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,InterestPayableCurrentAndNoncurrent,InvestmentIncomeInterest,LesseeOperatingLeaseLiabilityPaymentsDue,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAttributableToParentDiluted,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,PaidInKindInterest,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromConvertibleDebt,ProfitLoss,PropertyPlantAndEquipmentNet,ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent,SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfSharesOutstandingBasic,AccruedEmployeeBenefitsCurrent,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,DeferredOfferingCosts,DepositsAssetsCurrent,EarningsPerShareBasicAndDiluted,IncreaseDecreaseInDueFromRelatedParties,OtherAssetsCurrent,OtherPrepaidExpenseCurrent,PrepaidExpenseCurrent,PrepaidInsurance,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromWarrantExercises,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2021-06-30,2021-08-23,10-Q,"TRANSCODE THERAPEUTICS, INC.",RNAZ,CIK0001829635,USD,1216501.0,840455.0,149125.0,34514.0,34514.0,1000.0,1522265.0,540219.0,79567.0,79567.0,,1080858.0,0.0001,290000000.0,4636216.0,4636216.0,464.0,2125813.0,2240000.0,,107852.0,890452.0,6335.0,251810.0,,0.0,35525.0,0.6,0.51,2618000.0,3069000.0,312534.0,-42346.0,0.0,0.0,0.0,0.0,-3069000.0,2652145.0,143776.0,2770904.0,0.0,0.0,0.0,,,,41966.0,247285.0,1.0,74520.0,6558346.0,1522265.0,1533103.0,,,,2770904.0,2770904.0,3126432.0,355528.0,-355528.0,,,0.0001,10000000.0,0.0,0.0,460652.0,,,91594.0,9354.0,211752.0,-5176316.0,,,6430882.0,1792672.0,0.32,,,34145.0,-5036081.0,,5400184.0,4636216.0,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-15,10-Q,"TRANSCODE THERAPEUTICS, INC.",RNAZ,CIK0001829635,USD,1984657.0,107386.0,30669297.0,64051.0,64052.0,,25359852.0,25204242.0,22499856.0,22499856.0,,,0.0001,290000000.0,12904574.0,12904574.0,1291.0,,,,,,,220075.0,,0.0,,-0.2,,,,279166.0,1340.0,0.0,0.0,0.0,0.0,,,1366963.0,,0.0,,0.0,,,,333.0,,141.0,46575.0,2204732.0,25359852.0,2204732.0,,,,-2329706.0,,30203.0,2359909.0,-2359909.0,,,0.0001,10000000.0,0.0,0.0,2704386.0,,,155610.0,9446.0,992946.0,-7506022.0,,0.0,4786434.0,1792672.0,0.32,,,,23155120.0,,,11526514.0,34179.0,64752.0,5.0,312500.0,934427.0,9410.0,-0.2,,481565.0,164145.0,46283.0,2002983.0,,,4991431.0,25400673.0,11526514.0
